Fineline Cube

Follow:
14409 Articles
Sobi Acquires Arthrosi for $1.5 Billion to Add Gout Drug to Portfolio
CompanyDeals

Sobi Acquires Arthrosi for $1.5 Billion to Add Gout Drug to Portfolio

Novo Nordisk's Wegovy 7.2mg Gets EMA Positive Opinion for Obesity
CompanyDrug

Novo Nordisk’s Wegovy 7.2mg Gets EMA Positive Opinion for Obesity

Innovent's Mazdutide Wins Macau Approval for Weight Management
CompanyDrug

Innovent’s Mazdutide Wins Macau Approval for Weight Management

Kyinno Biotechnology Closes RMB 250M Series B for Bispecific Antibody Pipeline
CompanyDeals

Kyinno Biotechnology Closes RMB 250M Series B for Bispecific Antibody Pipeline

Cellular Origins Raises $40M Series A Led by Johnson & Johnson for Cell Therapy Manufacturing
CompanyDeals

Cellular Origins Raises $40M Series A Led by Johnson & Johnson for Cell Therapy Manufacturing

Akeso's Cadonilimab Wins FDA Nod for Global Phase 3 Gastric Cancer Study
CompanyDrug

Akeso’s Cadonilimab Wins FDA Nod for Global Phase 3 Gastric Cancer Study

China Healthcare Fund Settlement Reform Targets 3% Ratio by 2028
Policy / Regulatory

China Healthcare Fund Settlement Reform Targets 3% Ratio by 2028

Junshi Biosciences Wins FDA Nod for EGFR/HER3 Bispecific ADC in Solid Tumors
CompanyDrug

Junshi Biosciences Wins FDA Nod for EGFR/HER3 Bispecific ADC in Solid Tumors

Henlius Serplulimab NDA Wins Priority Review for Gastric Cancer as Adjuvant Therapy
CompanyDrug

Henlius Serplulimab NDA Wins Priority Review for Gastric Cancer as Adjuvant Therapy

Hanx Biopharma Prices HKEX IPO to Fund Bispecific Antibody Pipeline
CompanyDeals

Hanx Biopharma Prices HKEX IPO to Fund Bispecific Antibody Pipeline

China Unveils Elderly Nursing Plan to Boost 90% Nurse Coverage by 2027
Policy / Regulatory

China Unveils Elderly Nursing Plan to Boost 90% Nurse Coverage by 2027

Amgen’s Uplizna Scores Third FDA Indication in Myasthenia Gravis
CompanyDrug

Amgen’s Uplizna Scores Third FDA Indication in Myasthenia Gravis